Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€127.05

€127.05

3.910%
4.85
3.910%
€118.87
 
17.05.24 / Tradegate WKN: A2PH5P / Symbol: TMDX / Name: Transmedics Group / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Transmedics Group Inc Stock

A very strong showing by Transmedics Group Inc today, with an increase of €4.85 (3.910%) compared to yesterday's price.
We see a rather positive sentiment for Transmedics Group Inc with 13 Buy predictions and 1 Sell predictions.
However, we have a potential of -7.12% for Transmedics Group Inc as the target price of 118 € is below the current price of 127.05 €.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Transmedics Group Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Transmedics Group Inc in the next few years

Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) 14.82%
Target price 121.290
Change
Ends at 01.05.25

TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at TD Cowen from $100.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 14.82%
Target price 118.872
Change
Ends at 01.05.25

TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at JPMorgan Chase & Co. from $105.00 to $127.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 14.82%
Target price 112.308
Change
Ends at 01.05.25

TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $120.00 price target on the stock, up previously from $95.00.
Ratings data for TMDX provided by MarketBeat
Show more